Alvotech (ALVO) vs Xeris Biopharma Holdings, Inc. (XERS)
- Alvotech ALVO 5.00 −5.84%
- Xeris Biopharma Holdings, Inc. XERS 10.28 +2.09%
Alvotech and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $2.1B against $1.8B — 1.1× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against 36.3%. Xeris Biopharma Holdings, Inc. has the higher net margin (−5.12% vs −101.1%) and the higher return on invested capital (18.9% vs 0.00%). Across the 16 metrics below, Xeris Biopharma Holdings, Inc. leads on 11 and Alvotech on 5.
Valuation
Profitability
| Metric | ALVO | XERS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 86.58% | 53.94% |
| Operating margin | (42.43%) | 10.91% | 0.00% |
| Net margin | (101.05%) | (5.12%) | 0.00% |
| Free cash flow margin | 0.00% | 16.60% | 0.00% |
| Return on equity | 0.00% | 118.22% | (0.40%) |
| Return on assets | 0.00% | (4.60%) | (3.32%) |
| Return on invested capital | 0.00% | 18.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack